Literature DB >> 18475498

Compartmentalization of TNF and IL-6 in meningitis and septic shock.

A Waage1, A Halstensen, T Espevik, P Brandtzæg.   

Abstract

We examined the compartmentalization of bioactive tumour necrosis factor (TNF) and interleukin 6 (IL-6) to the subarachnoid space and systemic circulation in patients with meningococcal meningitis and septic shock/bacteraemia. In patients with meningitis, median levels of TNF in 31 paired samples of cerebrospinal fluid (CSF) and serum were respectively 783 pg/ml and below detection limit (p < 0.001) and median levels of IL-6 were 150 ng/ml and 0.3 ng/ml (p < 0.0001). In patients with septic shock without meningitis, median levels in paired samples of CSF and serum were respectively below detection limit and 65 pg/ml (not significant, (ns)) (TNF, eleven patients) and 1.3 ng/ml-3 ng/ml (ns) (IL-6, nine patients). The data show that TNF and IL-6 are localized to the subarachnoid space in patients with meningitis although the blood-brain barrier is penetrable to serum proteins. On the other hand, patients with septic shock tend to have cytokines in both serum and CSF.

Entities:  

Year:  1993        PMID: 18475498      PMCID: PMC2365385          DOI: 10.1155/S096293519300002X

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  7 in total

1.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

Review 2.  The structure and function of the blood-brain barrier.

Authors:  M W Bradbury
Journal:  Fed Proc       Date:  1984-02

3.  Bioactive and inactive forms of tumor necrosis factor-alpha in spinal fluid from patients with meningitis.

Authors:  B Møller; S C Mogensen; P Wendelboe; K Bendtzen; C M Petersen
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

4.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

5.  Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease.

Authors:  P Brandtzaeg; P Kierulf; P Gaustad; A Skulberg; J N Bruun; S Halvorsen; E Sørensen
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

6.  Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.

Authors:  A Waage; A Halstensen; R Shalaby; P Brandtzaeg; P Kierulf; T Espevik
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

7.  Ultrastructural localization of albumin transport across the cerebral microvasculature during experimental meningitis in the rat.

Authors:  V J Quagliarello; A Ma; H Stukenbrok; G E Palade
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

  7 in total
  5 in total

Review 1.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  A cyanobacterial lipopolysaccharide antagonist inhibits cytokine production induced by Neisseria meningitidis in a human whole-blood model of septicemia.

Authors:  Kim Jemmett; Annalisa Macagno; Monica Molteni; John E Heckels; Carlo Rossetti; Myron Christodoulides
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

3.  Interaction of Neisseria meningitidis with human meningeal cells induces the secretion of a distinct group of chemotactic, proinflammatory, and growth-factor cytokines.

Authors:  Myron Christodoulides; Benjamin L Makepeace; Kris A Partridge; Davindaur Kaur; Mark I Fowler; Roy O Weller; John E Heckels
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

4.  Virulence Studies of Different Sequence Types and Geographical Origins of Streptococcus suis Serotype 2 in a Mouse Model of Infection.

Authors:  Jean-Philippe Auger; Nahuel Fittipaldi; Marie-Odile Benoit-Biancamano; Mariela Segura; Marcelo Gottschalk
Journal:  Pathogens       Date:  2016-07-11

5.  Sequential analysis of biomarkers in cerebrospinal fluid and serum during invasive meningococcal disease.

Authors:  O Beran; D A Lawrence; N Andersen; O Dzupova; J Kalmusova; M Musilek; M Holub
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-10       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.